KMID : 1197720220150020146
|
|
´ëÇÑÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸÁö 2022 Volume.15 No. 2 p.146 ~ p.150
|
|
Long-Term Outcome of Hemimasticatory Spasm
|
|
Rayorcid Somdattaa
Kamble Nitish Yadav Ravi Pal Pramod Kumar
|
|
Abstract
|
|
|
Objective: This study aims to identify the demographic, clinical, and therapeutic characteristics of four patients with hemimasticatory spasm (HMS) seen in our outpatient department over a period of 20 years.
Methods: We performed a retrospective chart review of four patients with HMS who visited outpatient services in the Department of Neurology from 2001 to 2020.
Results: The follow-up for all patients ranged from 2 years to 9 years. Three patients had facial or bucco-oral morphea. Two patients maintained long-term improvements in symptoms after being treated with botulinum toxin for 4?7 years, while one patient reported improvement in symptoms with treatment of carbamazepine that subsequently remitted after pregnancy.
Conclusion: This report highlights the long-term outcome of HMS in our patients. Our patients reported a significant reduction or complete resolution of symptoms after treatment, and eventually, two patients were asymptomatic while off treatment.
|
|
KEYWORD
|
|
Botulinum toxin, Spasm, Outcome, Morphea
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|